Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-30T20:29:09.111Z Has data issue: false hasContentIssue false
  • English
  • Français

Group A Streptococcal Outbreaks in Nursing Homes

Published online by Cambridge University Press:  21 June 2016

Benjamin Schwartz  and
Xilla T. Ussery
Benjamin Schwartz*
Affiliation:
Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control, Atlanta, Georgia
Xilla T. Ussery
Affiliation:
Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control, Atlanta, Georgia
*
Mailstop C-09, Respiratory Diseases Branch, Centers for Disease Control, Atlanta, GA 30333
Get access Rights & Permissions [Opens in a new window]

Extract

Group A streptococci (Streptococcus pyogenes) are the most common bacterial cause of pharyngitis and a frequent cause of cutaneous infections including impetigo and cellulitis. More rarely, group A streptococci are implicated as the etiologic agent in patients with pneumonia, bacteremia, and a newly described toxic shock-like syndrome.' While invasive group A streptococcal infections occur in persons of all ages, the incidence of these infections is greatest in the elderly, as is the case/fatality ratio. Factors that may contribute to the increased risk of invasive group A streptococcal infections in the elderly include a higher prevalence of underlying illnesses and, possibly, decreased levels of antibodies directed against the group A streptococcal M-protein, a major determinant of virulence.

From the advent of the antibiotic era until the mid-1980s, the occurrence of severe group A streptococcal infections declined. However, since 1985, rheumatic fever outbreaks in civilian and military populations, a syndrome designated the streptococcal toxic shock-like syndrome, and an increased incidence of group A streptococcal bacteremia have been reported. These changes in the epidemiology of group A streptococcal infections have been associated with changes in the serotype distribution, with an increasing proportion of invasive infections caused by M-1 and M-3 strains, and an increase in the proportion of organisms producing pyrogenic exotoxin A, which has been linked to the toxic shock-like syndrome.

Type
Topics in Long-Term Care
Information
Infection Control & Hospital Epidemiology , Volume 13 , Issue 12 , December 1992 , pp. 742 - 747
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Cone, LA, Woodard, DR, Schilevert, PM, Tomory, GS. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes . N Engl J Med. 1987;317:146–149.Google Scholar
2. Francis, J, Warren, RE. Streptococcus pyogenes bacteraemia in Cambridge-A review of 67 episodes. Quart J Med. 1988:256:603–613.Google Scholar
3. Ispahani, P, Donald, FE, Aveline, AJD. Streptococcus pyogenes bacteraemia: an old enemy subdued, but not defeated. J Infect. 1988;16:37–46.CrossRefGoogle Scholar
4. Fischetti, VA. Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev. 1989;2:285–314.CrossRefGoogle ScholarPubMed
5. Quinn, RW. The epidemiology of group A streptococcal infections-their changing frequency and severity. Yale J Biol Med. 1982;55:265–270.Google Scholar
6. Veasy, GL, Weidmeier, SE, Orsmond, GS, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med. 1987;316:421–428.Google Scholar
7. Wallace, MR, Garst, PD, Papadimos, TJ, Oldfield, EC III. The return of acute rheumatic fever in young adults. JAMA. 1989;262:2557–2561.Google Scholar
8. Kaplan, EL, Johnson, DR, Cleary, PP. Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid-1980s. J Infect Dis. 1989;159:101–103.Google Scholar
9. Stevens, DL, Tanner, MH, Winship, J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med. 1989;321:1–7.Google Scholar
10. Centers for Disease Control. Group A beta-hemolytic streptococcal bacteremia-Colorado, 1989. MMWR. 1990;39:3–11.Google Scholar
11. Schwartz, B, Facklam, RR, Breiman, RF. Changing epidemiology of group A streptococcal infection in the USA. Lancet. 1990;336:1167–1171.Google Scholar
12. Talkington, DE Schwartz, B, Elliott, JA, Hoge, CW, Facklam, RR. Analysis of streptococcal pyrogenic exotoxin A and B, and M-type among invasive group A streptococcal strains [abstract B271]. In: Abstracts of the 91st General Meeting of the American Society for Microbiology Washington, D.C.: American Society for Microbiology; 1991.Google Scholar
13. Musser, JM, Hauser, AR, Kim, MH, Schlievert, PM, Nelson, K, Selander, RK. Streptococcus pyogenes causing the toxic shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Nat Acad Sci USA. 1991;88:2668–2672.CrossRefGoogle ScholarPubMed
14. Reid, RI, Briggs, RS, Seal, DV, Pearson, AD. Virulent Streptococcus pyogenes: outbreak and spread within a geriatric unit. J Infect. 1983;6:219–225.CrossRefGoogle ScholarPubMed
15. Ruben, FL, Norden, CW, Heisler, B, Korica, Y. An outbreak of Streptococcus pyogenes infections in a nursing home. Ann Intern Med. 1984;101:494–496.CrossRefGoogle ScholarPubMed
16. Pritchard, VG, Kerry, CS. Streptococcal outbreak. J Geront Nursing. 1988;14:19–23.Google Scholar
17. Harkness, GA, Bentley, DW, Mottley, M, Lee, J. Streptococcus pyogenes outbreak in a long-term care facility. Am J Infect Control. 1992;20:142–148 CrossRefGoogle ScholarPubMed
18. Centers for Disease Control. Nursing home outbreaks of invasive group A streptococcal infections-Illinois, Kansas, North Carolina, and Texas. MMWR. 1990;39:577–579.Google Scholar
19. Schwartz, B, Elliott, JA, Butler, JC, et al. Spread of invasive group A streptococcal infections in family, hospital, and nursing home settings. Clin Infect Dis. 1992;15:277–284.CrossRefGoogle ScholarPubMed
20. Auerbach, SB, Schwartz, B, Williams, D, et al. Outbreak of invasive group A streptococcal infections in a nursing home: lessons on prevention and control Arch Intern Med. 1992;152:1017–1022.CrossRefGoogle Scholar
21. Garibaldi, RA, Brodine, S, Matsumiya, S. Infections among patients in nursing homes. N Engl J Med. 1981;305:731–735.CrossRefGoogle ScholarPubMed
22. Kass, EH, Seastone, CV. The role of mucoid polysaccharide (hyaluronic acid) in the virulence of group A hemolytic streptococci. J Exp Med. 1944;79:319–330.CrossRefGoogle ScholarPubMed
23. Renneberg, J, Soderstrom, M, Prellner, K, Forsgren, A. Christensen, P. Age-related variations in anti-streptococcal antibody levels. Eur J Clin Microbiol Infect Dis. 1989;8:792–795.CrossRefGoogle ScholarPubMed
24. Ferrieri, P, Dajani, AS, Wannamaker, LW, et al. Natural history of impetigo. I. Site sequence of acquisition and familial patterns of spread of cutaneous streptococci. J Clin Invest. 1972;51:2851–2862.CrossRefGoogle ScholarPubMed
25. Garner, JS, Simmons, BP CDC guideline for isolation precautions in hospitals. Infect Control. 1983;4:245–325.Google Scholar
26. Gastanaduy, AS, Howe, B, Kaplan, EL, McKay, C, Wannamaker, LW. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. Luncet. 1980;ii:498–502.CrossRefGoogle Scholar
27. Chaudhary, S, Bilinsky, SA, Hennessy, JL, et al. Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: a randomized trial of 10 days penicillin vs 10 days penicillin with rifampin during the final 4 days of therapy. J Pediatr. 1985;106:481–486.CrossRefGoogle Scholar
28. Pichichero, ME, Disney, FA, Aronovitz, GH, Talpey, WB, Green, JL, Francis, AB. Randomized, single-blind evaluation of cefadroxil and phenoxymethyl penicillin in the treatment of streptococcal pharyngitis. Antimicrob Agents Chemother. 1987;31:903–906.CrossRefGoogle ScholarPubMed